Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

Blood. 2021 May 27;137(21):2992-2997. doi: 10.1182/blood.2020010150.

Tim H H Coorens¹, Grace Collord^{1

2

3}, Wanhua Lu⁴, Emily Mitchell^{1

4

5}, Jannat Ijaz¹, Thomas Roberts⁴, Thomas R W Oliver¹, G A Amos Burke⁴, Michael Gattens⁴, Emmy Dickens⁴, Jyoti Nangalia^{1

4

5

6}, Marc Tischkowitz⁷, John Anderson^{8

9}, Adam Shlien¹⁰, Anna L Godfrey⁴, Matthew J Murray^{4

11}, Sam Behjati^{1

4

12}

¹ Wellcome Sanger Institute, Hinxton, United Kingdom.
² Department of Haematology, University College London Hospital, London, United Kingdom.
³ Department of Haematology, University College London Cancer Institute, London, United Kingdom.
⁴ Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom.
⁵ Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
⁶ Cambridge Stem Cell Institute, Cambridge, Cambridgeshire, United Kingdom.
⁷ Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.
⁸ University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
⁹ Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
¹⁰ The Hospital for Sick Children, Toronto, ON, Canada; and.
¹¹ Department of Pathology and.
¹² Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.

No abstract available

Publication types